Home
Taysha Gene Therapies

Taysha Gene Therapies Market Share Analysis for July 2026

Health > Biotechnology and Pharmaceuticals

Domaintayshagtx.com

Year Founded2019

Employees51 - 200

Annual Revenue$25M - $50M

Taysha Gene Therapies

Taysha Gene Therapies (including company regionals)

tayshagtx.com

See more website traffic and engagement information

Taysha Gene Therapies Revenue up to July 2026 is 25M - 50M

revenue generated by Taysha Gene Therapies top domains

Taysha Gene Therapies top domains revenue over 3 years

Revenue for Taysha Gene Therapies top domains

tayshagtx.com25M - 50M

See more with Sales Intelligence

Total visits to Taysha Gene Therapies's top domains

Understand Taysha Gene Therapies market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

tayshagtx.com7.9K

See more with Sales Intelligence

Avg. visit duration in Taysha Gene Therapies's top domains

Analyze Taysha Gene Therapies engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

tayshagtx.com00:00:15

See more with Sales Intelligence

Avg. pageviews on Taysha Gene Therapies's top domains

See how Taysha Gene Therapies keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

tayshagtx.com1.73

See more with Sales Intelligence

Taysha Gene Therapies top competitors by domain

Top similar sites in July 2026, ranked by their affinity

encoded.comCompany NameEncoded Therapeutics, Inc.Employees51 - 200HQUnited States, California, South San FranciscoAnnual revenue$15M - $25MTotal visits13.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Taysha Gene Therapies

These are the website technologies, by industry, used by Taysha Gene Therapies top domains

Email Services (3)

Microsoft Exchange Online

Widget (3)

Twemoji

Marketing (2)

Google Marketing Platform

Mobile (2)

Meta Viewport

More Technologies

9

See all

News & Signals from Taysha Gene Therapies

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCatalent, Inc. partnered with Taysha GTx on Aug 3rd '26.Taysha Gene Therapies and Catalent expand strategic partnership to include future commercial manufacturing support of TSHA-102 gene therapy for Rett Syndrome.

NewsTaysha GTx attends event ASGCT 2026 Annual Meeting.Taysha Gene Therapies to present new preclinical data supporting construct design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting.

NewsTaysha GTx attends event 2025 IRSF Rett Syndrome Scientific Meeting.Taysha Gene Therapies announces details for oral presentations at the 2025 IRSF Rett Syndrome Scientific Meeting reviewing recent updates from the TSHA-102 clinical program.